M1A.4791 Other secondary chronic gout, unspecified ankle and foot, with tophus (tophi)

Name of the Condition

• Other Secondary Chronic Gout, Unspecified Ankle and Foot, with Tophus (tophi)

Summary

Other secondary chronic gout, unspecified ankle and foot, with tophus (tophi) is a form of arthritis affecting the ankle and foot joints, resulting from elevated uric acid levels due to an identifiable underlying condition or cause. It leads to recurrent joint inflammation and potential tissue damage, with symptoms that may persist over time. Advanced stages involve the formation of tophi (urate crystal deposits) in the ankle and foot areas.

Causes

Other secondary chronic gout, unspecified ankle and foot, with tophus (tophi) arises from an underlying condition that disrupts uric acid metabolism, causing accumulation in the blood. This can stem from overproduction of uric acid or reduced renal clearance due to factors like chronic kidney disease, certain medications, or hematologic disorders. Over time, urate crystals deposit in the ankle and foot joints and surrounding tissues, triggering inflammation and tophi formation.

Risk Factors

• Underlying conditions that affect uric acid metabolism (e.g., certain hematologic disorders, enzyme deficiencies)
• Medications that increase uric acid levels (e.g., some diuretics, chemotherapy agents)
• Chronic kidney disease or renal impairment
• History of gout or hyperuricemia
• Exposure to substances that disrupt uric acid excretion

Symptoms

• Recurrent episodes of intense ankle or foot pain, often with swelling
• Presence of tophi (visible or palpable urate crystal deposits) in the ankle and foot
• Joint stiffness or limited range of motion
• Redness and warmth over affected joints

Diagnosis

Diagnosis involves a combination of clinical evaluation, patient history, and laboratory tests. Joint fluid analysis may confirm urate crystals. Imaging (e.g., X-rays, ultrasound) can detect tophi or joint damage. Blood tests assess uric acid levels and rule out underlying conditions contributing to secondary gout.

Treatment Options

Treatment focuses on managing symptoms, reducing uric acid levels, and addressing the underlying cause. Medications may include anti-inflammatory drugs for acute flares, urate-lowering therapies, and agents to prevent tophi progression. Lifestyle modifications, such as dietary changes and hydration, support management.

Prognosis and Follow-Up

With proper treatment, symptoms can be controlled, and tophi may shrink or stabilize. However, chronic gout requires ongoing management to prevent flares and complications. Regular follow-up monitors uric acid levels, tophi progression, and treatment efficacy.

Complications

• Chronic joint damage or deformity
• Persistent pain or disability
• Tophi-related skin breakdown or infection
• Kidney stones or renal impairment from uric acid accumulation

Lifestyle & Prevention

• Maintain a balanced diet low in purines (e.g., limit red meat, seafood)
• Stay hydrated to support uric acid excretion
• Avoid alcohol and sugary beverages
• Manage weight and exercise regularly
• Follow prescribed medication regimens consistently

When to Seek Professional Help

Seek care if experiencing severe joint pain, swelling, or redness; new or worsening tophi; or symptoms that interfere with daily activities. Prompt evaluation is important for flare management and to adjust treatment as needed.

Tips for Medical Coders

Document the presence of tophi and specify the ankle and foot involvement. Ensure the underlying cause of secondary gout is clearly recorded, as this distinguishes it from primary gout. Code M1A.4791 is used when tophi are present and the ankle/foot location is unspecified.